Lee Gha-Hyun, Kim Jiyoung, Kim Hyun-Woo, Cho Jae Wook
Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Clin Neurol Neurosurg. 2021 Mar;202:106507. doi: 10.1016/j.clineuro.2021.106507. Epub 2021 Jan 19.
Polymerase chain reaction (PCR)-based testing of cerebrospinal fluid (CSF) samples has greatly facilitated the diagnosis of central nervous system (CNS) infections. However, the clinical significance of Epstein-Barr virus (EBV) DNA in CSF of individuals with suspected CNS infection remains unclear. We wanted to gain a better understanding of EBV as an infectious agent in immunocompetent patients with CNS disorders.
We identified cases of EBV-associated CNS infections and reviewed their clinical and laboratory characteristics. The study population was drawn from patients with EBV PCR positivity in CSF who visited Pusan National University Hospital between 2010 and 2019.
Of the 780 CSF samples examined during the 10-year study period, 42 (5.4 %) were positive for EBV DNA; 9 of the patients (21.4 %) were diagnosed with non-CNS infectious diseases, such as optic neuritis, Guillain-Barré syndrome, and idiopathic intracranial hypotension, and the other 33 cases were classified as CNS infections (22 as encephalitis and 11 as meningitis). Intensive care unit admission (13/33 patients, 39.3 %) and presence of severe neurological sequelae at discharge (8/33 patients, 24.2 %) were relatively frequent. In 10 patients (30.3 %), the following pathogens were detected in CSF in addition to EBV: varicella-zoster virus (n = 3), cytomegalovirus (n = 2), herpes simplex virus 1 (n = 1), herpes simplex virus 2 (n = 1), Streptococcus pneumomiae (n = 2), and Enterococcus faecalis (n = 1). The EBV-only group (n = 23) and the co-infection group (n = 10) did not differ in age, gender, laboratory data, results of brain imaging studies, clinical manifestations, or prognosis; however, the co-infected patients had higher CSF protein levels.
EBV DNA in CSF is occasionally found in the immunocompetent population; the virus was commonly associated with encephalitis and poor prognosis, and frequently found together with other microbes in CSF.
基于聚合酶链反应(PCR)的脑脊液(CSF)样本检测极大地促进了中枢神经系统(CNS)感染的诊断。然而,疑似CNS感染患者脑脊液中爱泼斯坦-巴尔病毒(EBV)DNA的临床意义仍不明确。我们希望更好地了解EBV作为免疫功能正常的CNS疾病患者的感染病原体的情况。
我们确定了EBV相关CNS感染病例,并回顾了其临床和实验室特征。研究人群来自2010年至2019年间就诊于釜山国立大学医院且脑脊液EBV PCR检测呈阳性的患者。
在为期10年的研究期间检测的780份脑脊液样本中,42份(5.4%)EBV DNA呈阳性;其中9例患者(21.4%)被诊断为非CNS感染性疾病,如视神经炎、格林-巴利综合征和特发性颅内低压,另外33例被归类为CNS感染(22例为脑炎,11例为脑膜炎)。入住重症监护病房(13/33例患者,39.3%)和出院时存在严重神经后遗症(8/33例患者,24.2%)的情况相对较为常见。10例患者(30.3%)的脑脊液中除EBV外还检测到以下病原体:水痘-带状疱疹病毒(n = 3)、巨细胞病毒(n = 2)、单纯疱疹病毒1型(n = 1)、单纯疱疹病毒2型(n = 1)、肺炎链球菌(n = 2)和粪肠球菌(n = 1)。单纯EBV感染组(n = 23)和合并感染组(n = 10)在年龄、性别、实验室数据、脑成像研究结果、临床表现或预后方面无差异;然而,合并感染患者的脑脊液蛋白水平较高。
免疫功能正常人群的脑脊液中偶尔会发现EBV DNA;该病毒通常与脑炎及不良预后相关,且在脑脊液中常与其他微生物共同存在。